PHATHOM PHARMACEUTICALS, INC. (PHAT) Holders breakdown
- Shares held by all insiders: Latest value (m).
- Shares held by institutions: Latest value (m).
- Float held by institutions: Latest value (m).
- Institutions holding shares: Latest value (m).
| Breakdown | Latest value |
|---|---|
| Shares held by all insiders | (m) |
| Shares held by institutions | (m) |
| Float held by institutions | (m) |
| Institutions holding shares | (m) |
History
| Date | Shares held by all insiders | Shares held by institutions | Float held by institutions | Institutions holding shares |
|---|---|---|---|---|
| (m) Historical records are unavailable. | ||||
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |